Rubio questions CDC on use of antibiotic as prophylactic against STIs

Published



Sen. Marco Rubio (R-FL) is questioning the Centers for Disease Control and Prevention over recent guidance for the prophylactic use of an antibiotic to prevent sexually transmitted infections, or STIs, raising the fear that the practice could have significant unintended consequences.

Rubio wrote to CDC Director Mandy Cohen this week asking about the agency’s preliminary recommendations for biological males who engage in same-sex intercourse to take the antibiotic doxycycline as a preventive measure against bacterial STIs. He said he is concerned that the recommendation will contribute to the problem of antimicrobial resistance, or AMR, when pathogens no longer respond to chemical medications to prevent and treat infectious diseases.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.